ALB and kidney failure: Other authors have reported that, in the absence of exogenous UII, palosuran potentiated glucose-induced insulin release in perfused rat pancreas [47] and decreased 24-hour urinary albumin excretion rate in diabetic patients with renal failure with regard to their disease progression [48].